Search All News
A new drug that penetrates the protective barrier around pancreatic cancers and accumulates in malignant cells may improve current chemotherapy, a study in mice suggests.
Researchers in Columbia's medical and engineering schools have edited a strain of non-pathogenic bacteria to colonize solid tumors in mice and safely deliver potent immunotherapies.
Barring ovarian cancer surgery at low-volume hospitals could limit access to care for many rural and underserved patients, a new study has found.
- September 28, 2018
Sarah Urke and Barbara Trencher, Columbia physical therapists and Velocity participants, developed an exercise program for cancer patients.
- September 20, 2018
Leaders in prostate cancer research and care will convene Sept. 22 for the inaugural NYC Prostate Cancer Summit, a patient-focused event co-hosted by CUIMC and NewYork-Presbyterian.
- August 27, 2018
Physician-scientist Darrell Yamashiro, MD, PhD, has been named director of Columbia's Division of Pediatric Hematology, Oncology, & Stem Cell Transplantation.
- July 30, 2018
Columbia researchers found that a gene associated with an autoimmune form of hair loss could be activated to improve cancer immunotherapy.
- July 10, 2018
Acupuncture significantly eased joint pain for a majority of women undergoing a common form of breast cancer treatment, a new study found.
- July 5, 2018
A very low carbohydrate, high-fat diet called the ketogenic diet may improve the effectiveness of an emerging class of cancer drugs, according to a study in mice.
- June 29, 2018
Cell-based therapy expert Pawel Muranski, MD, discusses the challenges of testing cancer immunotherapy drugs in new patient groups.
- June 20, 2018
Columbia researchers discover that DNA repair falters when cells can’t move damaged DNA to repair centers within the nucleus. The results could lead to better cancer treatments.